Best Hemasphere Journal Podcasts (2025)

1
Metabolism in hematology - Ep 3.4, Part 2 28:52

15d ago28:52

28:52

In this second part of a 2-part episode, Dr Charles De Bock engages with Prof Dr Petya Apostolova and Dr Jörg Büscher to explore the intricate relationship between metabolism and hematology, particularly focusing on #AML. They discuss the challenges and advancements in metabolomics, the importance of integrating multi-omics approaches, and the futu…

1
Metabolism in hematology - Episode 3.4, Part 1 29:51

15d ago29:51

29:51

In this 2-part episode of the HemaSphere podcast, host Dr Charles de Bock and guests Dr Jörg Büscher and Prof Dr Petya Apostolova discuss the critical role of metabolism in cellular function, particularly in the context of hematology and cancer research. The discussion highlights the technological advancements in metabolic analysis and their impact…

1
Machine learning for AML-MRD - Episode 3.3 29:24

1M ago29:24

29:24

In this episode of the HemaSphere podcast, host Charles de Bock and guest Tim Mocking, PhD, discuss the role of machine learning in the assessment of measurable residual disease (MRD) in acute myeloid leukemia (AML). They explore the challenges of MRD detection, the potential of machine learning to improve accuracy and efficiency, and the importanc…

1
Navigating Neutropenia: New Guidelines Explained - Episode 3.2 28:05

2M ago28:05

28:05

In this episode of the HemaSphere podcast, host Dr Charles De Bock discusses the newly published Guidelines on the treatment of neutropenias with co-authors Dr. Francesca Fioredda and Dr. Eleni Papadaki. They explore the importance of these international guidelines, the challenges faced in gathering evidence, and the consensus-building process amon…

1
Single‐cell DNA and surface protein - Episode 3.1 34:17

3M ago34:17

34:17

In this episode of the HemaSphere podcast, host Charles De Bock engages with HemaSphere Editor in Chief Professor Jan Cools, Professor Heidi Segers, and Doctor Margo Aertgeerts to discuss their recent study on acute lymphoblastic leukemia (ALL). They explore the advancements in treatment, particularly for high-hyperdiploid ALL, the challenges of re…

1
Two distinct fetal-type signatures characterize JMML - Episode 2.8 36:59

4M ago36:59

36:59

In this episode of the HemaSphere podcast, host Charles de Bock engages with Professor Hélène Cavé and Dr. Marion Strullu to discuss their recent study on juvenile myelomonocytic leukemia (JMML). They delve into the complexities of diagnosing JMML, the genetic mutations associated with the disease, and the prognostic factors that influence patient …

1
Revolutionizing Pediatric Cancer Research with PDXs - Episode 2.7 35:54

6M ago35:54

35:54

In this episode of the HemaSphere podcast, host Dr Charles de Bock discusses the critical role of mouse models in understanding leukemogenesis and hematopoiesis with Prof Richard Lock. They explore the significance of patient-derived xenografts (PDXs) in preclinical testing, the challenges faced in generating PDXs for acute myeloid leukemia (AML), …

1
Episode 2.6 - High 5hmC predicts worse OS 25:15

7M ago25:15

25:15

In this episode of the HemaSphere podcast, host Charles de Bock discusses the latest research on myelodysplastic syndrome (MDS) with Dr Francesca Tiso and Dr Florentien in 't Hout from Radboud University Medical Center, co-authors of a recent paper published in HemaSphere. The conversation covers the clinical presentation of MDS, treatment options,…

1
Episode 2.5 - Informed consent is almost impossible 39:11

9M ago39:11

39:11

This podcast episode delves into the complexities of informed consent in healthcare, particularly in the context of hematology. The discussion with host Dr Charles de Bock features insights from Dr Stephen Hibbs and Dr Louise Caldwell, authors of the HemaTopics "Informed consent is almost impossible” and guest Mark Dawson, a patient family member, …

1
Episode 2.4 - Best of Pediatric Hematology from EHA2024 42:24

10M ago42:24

42:24

In the latest episode, Dr Charles de Bock talks with Prof H. Josef Vormoor and Dr Maria Ester Bernardo, Chair and Co-Chair of EHA’s Pediatric Hematology Specialized Working Group. They discuss highlights from the EHA 2024 Congress in Madrid, including key lectures, new insights and what they could mean for clinicians, researchers, patients and thei…

1
Episode 2.3 - NOTCH1 fusions in T‐LBL 23:34

10M ago23:34

23:34

Authors of this recent HemaSphere published paper discovered a high-risk subgroup of pediatric T-LBL, defined by NOTCH1 gene fusions. This finding will have an important impact on newly diagnosed children with T-LBL globally, listen to two of the co-authors, Dr Jan Loeffen and Professor Roland Kuipers discuss their findings with Dr Charles de Bock,…

1
Episode 2.2 - A transcriptional cofactor‐mediated dependency module 24:48

1y ago24:48

24:48

In this newest podcast episode, Dr Charles de Bock hosts Dr Thomas Mercher and Dr Alexandre Fagnan. This episode is based on their recent paper, “The ETO2 transcriptional co-factor maintains acute leukemia by driving a MYB/EP300-dependent stemness program”, highlighting ETO2 activated gene transcription and how this affects erythroleukemia. The dis…

1
Episode 2.1 - Unraveling the secrets of thrombopoiesis 25:20

1y ago25:20

25:20

Welcome to Season 2 of our podcast! In this episode, Dr. Francesca Vinchi interviews Professor Alessandra Balduini about thrombopoiesis. They explore Prof. Balduini's journey into research, her intuition that led to silk scaffolding, and her hopes on future results. "Unraveling the secrets of thrombopoiesis", is on our website and all major podcast…

1
Episode 1.8 - What’s so Great About the P-value? A Statistician’s Point of View 30:24

1+ y ago30:24

30:24

Dr Stephen Hibbs invites HemaSphere Associate Editor Prof Robert K Hills to discuss statistics in scientific writing in an entertaining and informative episode: What’s so Great About the P-value? A Statistician’s Point of View. This discussion covers the overlap of statistics and hematology with themes like the importance of P value and the use of …

1
Episode 1.7 - This Is Going to Hurt: Revisiting the Patient Experience of Bone Marrow Biopsies 24:16

2y ago24:16

24:16

Dr Stephen Hibbs invites Dr Joseph Taylor to a discussion based on Dr Hibbs popular HemaTopics article, This Is Going to Hurt: Revisiting the Patient Experience of Bone Marrow Biopsies. The conversation ranges from the type of training providers receive, how to talk to patients about these bone marrow biopsies, and some of the outstanding questions…

1
Episode 1.6 - Part 1: The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children 27:29

2y ago27:29

27:29

Though many advances have been made in neutropenias, diagnosis and management are still based on physicians’ experience or local practices. Prof Francesca Fioredda and Prof Helen Papadaki, two co-authors of the HemaSphere published article The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between…

1
Episode 1.4, Part 1 - Comprehensive Diagnosis and Management of POEMS Syndrome 23:23

2y ago23:23

23:23

POEMS syndrome (Polyneuropathy Organomegaly, Endocrinopathy, M-protein and Skin changes) is rare, and systemic manifestations are commonly overlooked initially. Diagnosis is often delayed 12-16 months, during which patients can be severely disabled. No established treatment guidelines exist for POEMS. A recent HemaSphere published article, Comprehe…

1
Episode 1.5, Part 2 - Comprehensive Diagnosis and Management of POEMS Syndrome 24:32

2y ago24:32

24:32

POEMS syndrome (Polyneuropathy, Organomegaly, Endocrinopathy, M-protein and Skin changes) is rare, and systemic manifestations are commonly overlooked initially. Diagnosis is often delayed 12-16 months, during which patients can be severely disabled. No established treatment guidelines exist for POEMS. A recent HemaSphere published article Comprehe…

1
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis - Episode 1.3 34:01

2y ago34:01

34:01

Machine Learning is a subsection in the field of Artificial Intelligence. How can this be used as a tool in hematology-oncology for advanced disease prognostification and beyond? Adrián Mosquera-Orgueira and Juan Carlos Hernández-Boluda, two co-authors of the HemaSphere published article Machine Learning Improves Risk Stratification in Myelofibrosi…

1
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer - Episode 1.2 24:32

2y ago24:32

24:32

As the overall cancer death rate has declined over past decades and cancer survival has increased, unforeseen challenges are emerging. Thrombocytopenia, often associated with cancer disease or anticancer therapy, will be more present in thrombotic cancer patients, but evidence on how to treat these patients is lacking. Prof Anna Falanga discusses t…

1
Long COVID-19” of Researchers: What to Do Next? - Episode 1.1 20:07

2y ago20:07

20:07

What to do next for “Long COVID-19” of researchers? A survey from scientists to scientists led by the Young European Hematology Association (Young EHA)committee led to this discussion about how COVID-19 impacted researchers, especially earlier in their career and without a network. What tools did they discover to get through it? Find it on the Hema…

Podcasts Worth a Listen

Hemasphere Journal Podcasts

Podcasts Worth a Listen

1
HemaSphere Podcast

HemaSphere Journal

1
Metabolism in hematology - Ep 3.4, Part 2 28:52

1
Metabolism in hematology - Episode 3.4, Part 1 29:51

1
Machine learning for AML-MRD - Episode 3.3 29:24

1
Navigating Neutropenia: New Guidelines Explained - Episode 3.2 28:05

1
Single‐cell DNA and surface protein - Episode 3.1 34:17

1
Two distinct fetal-type signatures characterize JMML - Episode 2.8 36:59

1
Revolutionizing Pediatric Cancer Research with PDXs - Episode 2.7 35:54

1
Episode 2.6 - High 5hmC predicts worse OS 25:15

1
Episode 2.5 - Informed consent is almost impossible 39:11

1
Episode 2.4 - Best of Pediatric Hematology from EHA2024 42:24

1
Episode 2.3 - NOTCH1 fusions in T‐LBL 23:34

1
Episode 2.2 - A transcriptional cofactor‐mediated dependency module 24:48

1
Episode 2.1 - Unraveling the secrets of thrombopoiesis 25:20

1
Episode 1.8 - What’s so Great About the P-value? A Statistician’s Point of View 30:24

1
Episode 1.7 - This Is Going to Hurt: Revisiting the Patient Experience of Bone Marrow Biopsies 24:16

1
Episode 1.6 - Part 1: The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children 27:29

1
Episode 1.4, Part 1 - Comprehensive Diagnosis and Management of POEMS Syndrome 23:23

1
Episode 1.5, Part 2 - Comprehensive Diagnosis and Management of POEMS Syndrome 24:32

1
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis - Episode 1.3 34:01

1
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer - Episode 1.2 24:32

1
Long COVID-19” of Researchers: What to Do Next? - Episode 1.1 20:07

Quick Reference Guide